6,777,233 covering composition-of-matter claims for the human neural stem cell, including cultures derived from embryonic, fetal, neonatal and adult tissue
AntiCancer Inc., of San Diego, received a patent covering the use of fluorescent proteins for the imaging of cancer, gene expression, stem cells and other processes in animals, as well as humans
6,667,034 B2 covering a method of bone marrow transplantation, often referred to as stem cell transplants, using cells produced with Aastrom's single-pass perfusion technology that enables the growth of normal human cells outside the body
6,569,427 and 6,605,275 related to the therapeutic use of fetal and neonatal stem cells for hemapoietic or immune reconstitution and hematopoietic reconstitution in gene therapy
6,541,247 titled "Method of Isolating Ependymal Neural Stem Cells...The privately held company said the issuance marks the first patent covering a specific stem cell type in adult brains
6,576,464, with claims directed to pluripotent stem cells that are engineered to permit the elimination of any undifferentiated cells that might remain after production of a batch of differentiated cells...The technology would be used, if needed, to provide an additional level of safety for cell therapies made from human embryonic stem cells
6,506,574 covering the use of hepatocytes derived from human embryonic stem cells (hESCs) for drug screening...6,497,872 with broad claims covering the transplantation of mammalian tissue-derived neural stem cells and their progeny into the central nervous system and the peripheral nervous system including the spinal cord
6,461,645 for pharmaceutical compositions of human hematopoietic stem cells derived from umbilical cord or placental blood, cryopreserved for future therapeutic use
6,458,589 with claims directed to hepatocytes derived from human embryonic stem cells...patent issued to Geron arising from its internal development of human embryonic stem cell technology and products
6,326,198 titled “Methods and Compositions for the Ex Vivo Replication of Stem Cells, for the Optimization of Hematopoietic Progenitor Cell Cultures, and for Increasing the Metabolism, GM-CSF Secretion and/or IL-6 Secretion of Human Stromal Cells
6,284,539, protecting its method for inducing neural stem cells to a dopaminergic fate via the introduction of the Nurr1 gene and its homologues into the cells
6,242,252 titled Hepatic Progenitors and Methods of Isolating Same. It covers stem cells that are potentially capable of growth and maturation into liver tissue
patents covering a method to separate neural stem cells for growth in culture and a unique murine model for identifying stem-progenitor cells for the pancreas and liver
6,777,233 covering composition-of-matter claims for the human neural stem cell, including cultures derived from embryonic, fetal, neonatal and adult tissue